Xbiom Insights: A Unified Data Hub for Development and Research in Life Sciences
This article aims to provide information about Xbiom Insights, a powerful and comprehensive data hub designed for development and research in the life sciences. Developed by PointCross Life Sciences, Xbiom Insights offers a unified platform that enables seamless integration of various research activities and departments, while providing advanced data science and AI capabilities. In this article, we will explore the key features and use cases of Xbiom Insights, demonstrating its value for sponsors and biotech companies.
Unified Data Hub and Compliance
Xbiom Insights is fully compliant with FAIR (Findable, Accessible, Interoperable, and Reusable) principles, ensuring that your data is organized and easily accessible. It is available as a software-as-a-service (SaaS) solution, specifically tailored to meet the needs of both sponsors and biotech organizations. By serving as a unified data hub, Xbiom Insights facilitates the integration of multiple data sources and offers various integration points to map source data effectively.
Let’s dive into three compelling use cases that highlight the benefits of Xbiom Insights:
- Large Sponsor: Phase Three Study Optimization By reanalyzing biomarkers and adverse event (AE) MCCs from six studies, Xbiom Insights helped a large sponsor reduce the study design timeline by six months. The research team was able to rapidly optimize the study design and enhance patient profiling, ultimately improving the overall efficiency and success of the study.
- Biotech Pilot: Biomarker Hypothesis Validation In just two weeks, Xbiom Insights successfully loaded and delivered analysis for six studies for a biotech company. Shortly after receiving the analysis, the biotech could validate a biomarker hypothesis that had been challenging to confirm for nearly a year. This accelerated validation process enabled the company to make significant progress in their research and development efforts.
- Large Sponsor: Internal Study Monitoring Xbiom Insights currently supports over six thousand studies within an internal registry for a large sponsor. This comprehensive platform allows sponsored teams to monitor studies with automatic nightly and weekly updates. Additionally, scientists can relate compound families, dose-response, and pathology translationally, facilitating better understanding and decision-making.
One of the key strengths of Xbiom Insights lies in its ability to seamlessly integrate and map various types of data, including studies, clinical trials, and molecular biomarker data. This integration unlocks the power of finding and comparing cohorts that meet specific criteria, enabling differential data analysis. Xbiom Insights maps data from in vitro, in vivo, omics, and biosamples, functioning akin to a GPS that standardizes data formats, terminologies, and metadata, making it easily queryable.
Illustrative Use Case
Let’s explore a use case that demonstrates how a scientist can query and stratify a patient cohort in Xbiom Insights for analysis:
Suppose a scientist wants to find cohorts treated with a specific compound and examine changes in gene expression levels involved in pathways and immune response within the cholangiocarcinoma tumor tissue environment. Using Xbiom Insights, the scientist selects patients treated with the compound from the study summary level, narrowing down the selection based on disease/indication, baseline parameters (age group and sex), and clinical endpoint (overall survival days > 365). Furthermore, molecular biomarkers related to DNA variation are chosen for advanced search, and the query mask is developed to filter datasets based on suspected gene sets contributing to cholangiocarcinoma. The resulting datasets are ready for analysis, allowing for interactive visualization and discovery of insights.